001     169274
005     20240612102722.0
024 7 _ |a pmc:PMC9999291
|2 pmc
024 7 _ |a 10.1016/j.neuron.2022.10.020
|2 doi
024 7 _ |a pmid:36327895
|2 pmid
024 7 _ |a 0896-6273
|2 ISSN
024 7 _ |a 1097-4199
|2 ISSN
024 7 _ |a altmetric:137964928
|2 altmetric
037 _ _ |a DZNE-2023-00112
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Paolicelli, Rosa C
|b 0
245 _ _ |a Microglia states and nomenclature: A field at its crossroads.
260 _ _ |a New York, NY
|c 2022
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1718180826_28348
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Microglial research has advanced considerably in recent decades yet has been constrained by a rolling series of dichotomies such as 'resting versus activated' and 'M1 versus M2.' This dualistic classification of good or bad microglia is inconsistent with the wide repertoire of microglial states and functions in development, plasticity, aging, and diseases that were elucidated in recent years. New designations continuously arising in an attempt to describe the different microglial states, notably defined using transcriptomics and proteomics, may easily lead to a misleading, although unintentional, coupling of categories and functions. To address these issues, we assembled a group of multidisciplinary experts to discuss our current understanding of microglial states as a dynamic concept and the importance of addressing microglial function. Here, we provide a conceptual framework and recommendations on the use of microglial nomenclature for researchers, reviewers, and editors, which will serve as the foundations for a future white paper.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 2
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Microglia
|2 MeSH
700 1 _ |a Sierra, Amanda
|b 1
700 1 _ |a Stevens, Beth
|b 2
700 1 _ |a Tremblay, Marie-Eve
|b 3
700 1 _ |a Aguzzi, Adriano
|b 4
700 1 _ |a Ajami, Bahareh
|b 5
700 1 _ |a Amit, Ido
|b 6
700 1 _ |a Audinat, Etienne
|b 7
700 1 _ |a Bechmann, Ingo
|b 8
700 1 _ |a Bennett, Mariko
|b 9
700 1 _ |a Bennett, Frederick
|b 10
700 1 _ |a Bessis, Alain
|b 11
700 1 _ |a Biber, Knut
|b 12
700 1 _ |a Bilbo, Staci
|b 13
700 1 _ |a Blurton-Jones, Mathew
|b 14
700 1 _ |a Boddeke, Erik
|b 15
700 1 _ |a Brites, Dora
|b 16
700 1 _ |a Brône, Bert
|b 17
700 1 _ |a Brown, Guy C
|b 18
700 1 _ |a Butovsky, Oleg
|b 19
700 1 _ |a Carson, Monica J
|b 20
700 1 _ |a Castellano, Bernardo
|b 21
700 1 _ |a Colonna, Marco
|b 22
700 1 _ |a Cowley, Sally A
|b 23
700 1 _ |a Cunningham, Colm
|b 24
700 1 _ |a Davalos, Dimitrios
|b 25
700 1 _ |a De Jager, Philip L
|b 26
700 1 _ |a de Strooper, Bart
|b 27
700 1 _ |a Denes, Adam
|b 28
700 1 _ |a Eggen, Bart J L
|b 29
700 1 _ |a Eyo, Ukpong
|b 30
700 1 _ |a Galea, Elena
|b 31
700 1 _ |a Garel, Sonia
|b 32
700 1 _ |a Ginhoux, Florent
|b 33
700 1 _ |a Glass, Christopher K
|b 34
700 1 _ |a Gökce, Ozgun
|0 P:(DE-2719)9002754
|b 35
|u dzne
700 1 _ |a Gomez-Nicola, Diego
|b 36
700 1 _ |a González, Berta
|b 37
700 1 _ |a Gordon, Siamon
|b 38
700 1 _ |a Graeber, Manuel B
|b 39
700 1 _ |a Greenhalgh, Andrew D
|b 40
700 1 _ |a Gressens, Pierre
|b 41
700 1 _ |a Greter, Melanie
|b 42
700 1 _ |a Gutmann, David H
|b 43
700 1 _ |a Haass, Christian
|0 P:(DE-2719)2202037
|b 44
700 1 _ |a Heneka, Michael
|0 P:(DE-2719)2000008
|b 45
700 1 _ |a Heppner, Frank L
|0 P:(DE-2719)2812386
|b 46
700 1 _ |a Hong, Soyon
|b 47
700 1 _ |a Hume, David A
|b 48
700 1 _ |a Jung, Steffen
|b 49
700 1 _ |a Kettenmann, Helmut
|b 50
700 1 _ |a Kipnis, Jonathan
|b 51
700 1 _ |a Koyama, Ryuta
|b 52
700 1 _ |a Lemke, Greg
|b 53
700 1 _ |a Lynch, Marina
|b 54
700 1 _ |a Majewska, Ania
|b 55
700 1 _ |a Malcangio, Marzia
|b 56
700 1 _ |a Malm, Tarja
|b 57
700 1 _ |a Mancuso, Renzo
|b 58
700 1 _ |a Masuda, Takahiro
|b 59
700 1 _ |a Matteoli, Michela
|b 60
700 1 _ |a McColl, Barry W
|b 61
700 1 _ |a Miron, Veronique E
|b 62
700 1 _ |a Molofsky, Anna Victoria
|b 63
700 1 _ |a Monje, Michelle
|b 64
700 1 _ |a Mracsko, Eva
|b 65
700 1 _ |a Nadjar, Agnes
|b 66
700 1 _ |a Neher, Jonas J
|0 P:(DE-2719)2811021
|b 67
700 1 _ |a Neniskyte, Urte
|b 68
700 1 _ |a Neumann, Harald
|b 69
700 1 _ |a Noda, Mami
|b 70
700 1 _ |a Peng, Bo
|b 71
700 1 _ |a Peri, Francesca
|b 72
700 1 _ |a Perry, V Hugh
|b 73
700 1 _ |a Popovich, Phillip G
|b 74
700 1 _ |a Pridans, Clare
|b 75
700 1 _ |a Priller, Josef
|0 P:(DE-2719)2811122
|b 76
700 1 _ |a Prinz, Marco
|b 77
700 1 _ |a Ragozzino, Davide
|b 78
700 1 _ |a Ransohoff, Richard M
|b 79
700 1 _ |a Salter, Michael W
|b 80
700 1 _ |a Schaefer, Anne
|b 81
700 1 _ |a Schafer, Dorothy P
|b 82
700 1 _ |a Schwartz, Michal
|b 83
700 1 _ |a Simons, Mikael
|0 P:(DE-2719)2811642
|b 84
700 1 _ |a Smith, Cody J
|b 85
700 1 _ |a Streit, Wolfgang J
|b 86
700 1 _ |a Tay, Tuan Leng
|b 87
700 1 _ |a Tsai, Li-Huei
|b 88
700 1 _ |a Verkhratsky, Alexei
|b 89
700 1 _ |a von Bernhardi, Rommy
|b 90
700 1 _ |a Wake, Hiroaki
|b 91
700 1 _ |a Wittamer, Valérie
|b 92
700 1 _ |a Wolf, Susanne A
|0 P:(DE-HGF)0
|b 93
700 1 _ |a Wu, Long-Jun
|b 94
700 1 _ |a Wyss-Coray, Tony
|b 95
773 _ _ |a 10.1016/j.neuron.2022.10.020
|g Vol. 110, no. 21, p. 3458 - 3483
|0 PERI:(DE-600)2001944-0
|n 21
|p 3458 - 3483
|t Neuron
|v 110
|y 2022
|x 0896-6273
856 4 _ |u https://pub.dzne.de/record/169274/files/DZNE-2023-00112_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/169274/files/DZNE-2023-00112_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:169274
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 35
|6 P:(DE-2719)9002754
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 44
|6 P:(DE-2719)2202037
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 45
|6 P:(DE-2719)2000008
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 46
|6 P:(DE-2719)2812386
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 67
|6 P:(DE-2719)2811021
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 76
|6 P:(DE-2719)2811122
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 84
|6 P:(DE-2719)2811642
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 2
914 1 _ |y 2022
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-16
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURON : 2021
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-16
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-16
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NEURON : 2021
|d 2022-11-16
920 1 _ |0 I:(DE-2719)5000007
|k AG Priller
|l Translational Neuropsychiatry
|x 0
920 1 _ |0 I:(DE-2719)1210012
|k AG Neher
|l Neuroimmunology and Neurodegenerative Disease
|x 1
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 2
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass
|l Molecular Neurodegeneration
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000007
980 _ _ |a I:(DE-2719)1210012
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a I:(DE-2719)1110007
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21